CIK: 0001802528 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 9, 2022
Total Value ($000): $568,894 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXSM | AXSOME THERAPEUTICS INC | 1,896,647 | $84,628 | 14.9% | $44.97 | +11.1% | COM | 05464T104 |
| COGT | COGENT BIOSCIENCES INC | 2,758,975 | $41,164 | 7.2% | $9.18 | +49.4% | COM | 19240Q201 |
| NUVL | NUVALENT INC | 2,079,863 | $40,433 | 7.1% | $20.57 | -18.6% | COM | 670703107 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 2,543,107 | $32,043 | 5.6% | $10.32 | +24.8% | COM | 09058V103 |
| — | BIOHAVEN PHARMACTL HLDG CO | 204,743 | $30,951 | 5.4% | $125.18 | — | COM | G11196105 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 283,000 | $30,057 | 5.3% | $92.29 | +9.9% | COM | 64125C109 |
| INSM | INSMED INC | 1,336,368 | $28,785 | 5.1% | $23.15 | +3.6% | COM PAR $.01 | 457669307 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,369,623 | $28,091 | 4.9% | $15.80 | +13.8% | COM | 92790C104 |
| — | VERONA PHARMA PLC | 2,678,982 | $27,379 | 4.8% | $8.60 | — | SPONSORED ADS | 925050106 |
| — | AXSOME THERAPEUTICS INC | 600,000 | $26,772 | 4.7% | — | — | Call | 05464T904 |
| ARGX | ARGENX SE | 73,526 | $25,958 | 4.6% | $266.01 | — | SPONSORED ADR | 04016X101 |
| ENTA | ENANTA PHARMACEUTICALS INC | 469,264 | $24,341 | 4.3% | $60.43 | -3.3% | COM | 29251M106 |
| — | POINT BIOPHARMA GLOBAL INC | 2,833,950 | $21,906 | 3.9% | $7.52 | — | COM | 730541109 |
| ANNX | ANNEXON INC | 3,358,563 | $20,756 | 3.6% | $4.53 | +19.3% | COM | 03589W102 |
| — | DBV TECHNOLOGIES SA | 7,064,964 | $12,505 | 2.2% | $2.30 | — | SPONSORED ADR | 23306J101 |
| TYRA | TYRA BIOSCIENCES INC | 1,416,998 | $12,455 | 2.2% | $14.88 | -38.5% | COM | 90240B106 |
| ACAD | ACADIA PHARMACEUTICALS INC | 751,804 | $12,300 | 2.2% | $31.03 | -47.8% | COM | 004225108 |
| TERN | TERNS PHARMACEUTICALS INC | 2,050,000 | $12,075 | 2.1% | $3.72 | 0.0% | COM | 880881107 |
| ONC | BEIGENE LTD | 86,400 | $11,648 | 2.0% | $161.85 | — | SPONSORED ADR | 07725L102 |
| KROS | KEROS THERAPEUTICS INC | 272,498 | $10,251 | 1.8% | $54.40 | -36.3% | COM | 492327101 |
| TRVI | TREVI THERAPEUTICS INC | 5,696,515 | $8,773 | 1.5% | $3.04 | +7.7% | COM | 89532M101 |
| — | ASTRIA THERAPEUTICS INC | 911,736 | $8,242 | 1.4% | $8.84 | — | COM | 04635X102 |
| — | AMARIN CORP PLC | 5,584,837 | $6,087 | 1.1% | $6.11 | — | SPONS ADR NEW | 023111206 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 389,588 | $3,732 | 0.7% | $24.87 | -53.6% | COM | 462260100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1,231,566 | $3,399 | 0.6% | $5.51 | -23.0% | COM | 68062P106 |
| — | INSTIL BIO INC | 673,905 | $3,262 | 0.6% | $24.02 | — | COM | 45783C101 |
| — | ALLAKOS INC | 147,189 | $901 | 0.2% | $84.51 | — | COM | 01671P100 |